Compugen Ltd. (CGEN) Stock Forecast
CGEN analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 5 analysts
- Price target
- $4.60 average of analyst targets
- Upside to target
- +134.7% from the latest close
- Next earnings
- November 9, 2026 EPS estimate $-0.08
- 52-week range
- $1.47 – $3.10
CGEN analyst ratings
5 analystsNumber of analysts at each rating.
CGEN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CGEN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.09 | −$0.10 | −$0.07 | −$0.07 | −23.8% | 3 |
| Current fiscal year (2026) | −$0.33 | −$0.35 | −$0.30 | $0.38 | −186.8% | 3 |
| Next fiscal year (2027) | −$0.37 | −$0.41 | −$0.31 | −$0.33 | −11.1% | 3 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CGEN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $975,000 | $0 | $2.5M | −48.4% | 4 |
| Current fiscal year (2026) | $9.2M | $4.8M | $17.6M | −87.3% | 4 |
| Next fiscal year (2027) | $7.8M | $0 | $25.0M | −16.1% | 4 |
CGEN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CGEN revenue: reported and forecast
CGEN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.09 | −$0.09 | −$0.09 | −$0.09 | −$0.09 | +2.0% | 0 up · 0 down |
| Current fiscal year (2026) | −$0.34 | −$0.33 | −$0.33 | −$0.33 | −$0.33 | −2.9% | 1 up · 0 down |
| Next fiscal year (2027) | −$0.36 | −$0.36 | −$0.37 | −$0.37 | −$0.37 | +0.5% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CGEN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CGEN beat in 9 of 12.
What analysts expect from CGEN
5 analysts cover Compugen; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $4.60, 134.7% above the latest close of $1.96. Analysts expect earnings of −$0.33 per share for 2026, −186.8% from a year earlier. For 2027 the average estimate is −$0.37 per share on revenue of $7.8 million. Compugen beat the EPS estimate in 9 of the last 12 quarters.
Related: CGEN income statement, CGEN key metrics, CGEN chart. See the CGEN stock overview for the latest quote and news.
CGEN forecast FAQ
What is Compugen's price target?
The average analyst price target for Compugen is $4.60, 134.7% above the latest close of $1.96.
Is Compugen a buy, hold or sell?
Of 5 analysts covering Compugen, 5 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Compugen's EPS forecast?
Analysts forecast −$0.33 per share for 2026 (range −$0.35 to −$0.30); for 2027 the estimate is −$0.37.
What is Compugen's revenue forecast?
The average revenue estimate for 2026 is $9.2 million, growth of −87.3%; for 2027 it is $7.8 million.
When does Compugen report earnings?
Compugen is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 before the market opens; the EPS estimate is $-0.08.
Does Compugen usually beat earnings estimates?
Compugen reported EPS at or above the analyst estimate in 9 of the last 12 quarters.